Study Title
A Prospective, Observational study in Patients Diagnosed with Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL), treated with Valchlor® (PROVe)
Purpose
To describe clinical characteristics, treatment & response patterns, and assess outcomes in patients with MF-CTCL treated with Valchlor during the study observation period.
Eligibility
All adult patients (≥ 18 years of age) diagnosed with MF-CTCL
Being treated with Valchlor
This includes patients newly initiating Valchlor or patients continuing treatment with Valchlor
Study Process
Contact Principal Investigator for Information
Trial Details
Investigator:
Michael Moore, M.D.
IRB:
Western
IRB Number:
Trial Type:
NA
Sponsor:
Actelion
Contact Information:
Hematology Oncology Associates
(318) 212-8620
http://cancer.wkhs.com